CDC: Surveillance for AIDS-Defining Opportunistic Illnesses, 1992-1997
Table 9
From U.S. Centers for Disease Control and Prevention
April 19, 1999
TABLE 9. Percentage* of persons with specific opportunistic illnesses during the course of acquired immunodeficiency syndrome for decedents, by disease and year of death -- Adult/Adolescent Spectrum of HIV Disease project,+ 1992-1997 |
| Disease |
Total (N=10,353) |
1992 (N=2,045) |
1993 (N=2,256) |
1994 (N=2,197) |
1995 (N=1,959) |
1996 (N=1,291) |
1997 (N=605) |
Trend&
|
Pneumocystis carinii
pneumonia |
53.0 |
57.9 |
55.6 |
51.7 |
47.2 |
52.6 |
43.4 |
decreasing |
Mycobacterium avium
complex |
30.0 |
31.9 |
29.6 |
28.3 |
30.9 |
30.3 |
23.1 |
none |
| Esophageal candidiasis |
24.4 |
24.6 |
24.5 |
21.5 |
25.8 |
26.9 |
30.1 |
none |
| Kaposi sarcoma |
22.6 |
25.0 |
24.9 |
22.2 |
19.6 |
19.1 |
20.5 |
none |
| Wasting syndrome |
20.8 |
22.9 |
21.5 |
17.8 |
20.7 |
20.7 |
27.5 |
increasing |
| Cytomegalovirus retinitis |
20.6 |
21.3 |
21.2 |
20.3 |
20.2 |
19.7 |
18.9 |
none |
| HIV encephalopathy |
13.5 |
14.1 |
12.1 |
15.1 |
14.0 |
11.3 |
11.4 |
none |
| Cytomegalovirus disease |
12.9 |
15.7 |
12.6 |
10.7 |
13.0 |
12.9 |
12.9 |
none |
| Extrapulmonary cryptococcosis |
8.1 |
8.4 |
9.0 |
6.6 |
8.3 |
8.7 |
9.1 |
none |
| Recurrent pneumonia |
7.4 |
5.7 |
6.9 |
8.7 |
8.5 |
6.9 |
8.0 |
increasing |
| Toxoplasmosis of brain |
7.2 |
9.3 |
7.3 |
7.1 |
5.8 |
5.7 |
5.7 |
decreasing |
| Pulmonary tuberculosis |
6.8 |
5.2 |
5.8 |
8.4 |
7.7 |
6.7 |
7.3 |
increasing |
| Chronic cryptosporidiosis |
5.9 |
5.9 |
5.3 |
6.0 |
6.6 |
5.8 |
5.8 |
none |
| Chronic herpes simplex |
4.9 |
4.6 |
5.2 |
5.0 |
4.7 |
4.7 |
3.5 |
none |
| Extrapulmonary tuberculosis |
4.1 |
4.2 |
4.4 |
4.2 |
4.4 |
3.0 |
1.6 |
decreasing |
Other disseminated
Mycobacterium |
3.3 |
3.9 |
4.3 |
3.0 |
2.2 |
2.6 |
1.8 |
decreasing |
| Immunoblastic lymphoma |
3.0 |
3.1 |
3.0 |
2.4 |
3.2 |
2.8 |
6.0 |
none |
Progressive multifocal
leukoencephalopathy |
2.7 |
2.6 |
2.3 |
2.7 |
2.9 |
3.1 |
1.8 |
none |
| Primary brain lymphoma |
2.1 |
1.9 |
1.8 |
2.3 |
2.5 |
1.8 |
1.7 |
none |
| Invasive cervical cancer@
|
2.0 |
2.0 |
1.0 |
2.5 |
1.9 |
2.9 |
1.6 |
none |
| Disseminated histoplasmosis |
1.6 |
2.3 |
1.9 |
1.3 |
1.4 |
1.1 |
1.7 |
none |
| Pulmonary candidiasis |
1.0 |
1.1 |
0.9 |
1.1 |
1.1 |
0.4 |
0.1 |
decreasing |
| Burkitts lymphoma |
0.9 |
0.6 |
1.2 |
1.0 |
0.5 |
1.0 |
0.7 |
none |
| Disseminated coccidioidomycosis |
0.2 |
0.1 |
0.2 |
0.2 |
0.1 |
0.3 |
0.1 |
none |
Recurrent Salmonella
septicemia |
0.2 |
0.3 |
0.4 |
0.1 |
0.1 |
0.1 |
0.0 |
none |
| Chronic isosporiasis |
0.1 |
0.1 |
0.1 |
0.1 |
0.1 |
0.1 |
0.0 |
none |
|
* The numerator is the number of persons who ever had a given opportunistic illness (OI); the denominator is the number of persons who died with one or more acquired immunodeficiency syndrome (AIDS)-defining OIs during 1992-1997. These data are standardized to national AIDS deaths by age, race, country of birth, sex, and human immunodeficiency virus (HIV) exposure mode. Data for all cities are weighted equally.
+ A CDC-sponsored surveillance project that collects data at selected sites in 11 U. S. cities.
Advertisement& -- The direction of change is given for trends that were significant (p<0.05) based on the stratified (HIV exposure mode, race, sex, age, metropolitan area, and country of birth) Cochran-Mantel-Haenszel statistic.
@ -- Restricted to women.
|
|
|
Advertisement
|
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication Morbidity and Mortality Weekly Report.
Email
Print-Friendly
Glossary
